Takeda Oncology

Home
United States
Cambridge, MA
Takeda Oncology

We aspire to cure cancer, with inspiration from patients and innovation from everywhere. At Takeda, we are united by our aspiration to cure cancer.

Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in the lives of people with cancer. Our research and development efforts are focused on advancing medicines for thoracic, gastrointestinal and hematologic cancers by leveraging modalities best

suited to treat these diseases. Our global in-house expertise and innovation are complemented by our valued partners. We fuel these relationships with respect, scientific rigor and a shared commitment to address the most urgent needs of patients. Our diverse global team fosters an inclusive environment where employees are welcomed, empowered and inspired. We are committed to ensuring that patients globally can benefit from and access our portfolio of medicines, while also progressing a pipeline of potential treatments for the future. For more information, visit www.takedaoncology.com. Review our social media community guidelines: https://www.takedaoncology.com/social-media-policy/.

08/28/2026

The FDA has approved a new first-in-class treatment for erythrocytosis in adults with ( ).

This approval marks significant progress for the PV community, and we're grateful to the patients, care partners and advocates who helped make this milestone possible.

Read the full announcement here: https://www.takedaoncology.com/newsroom/news-releases/2026/fda-approval-mimrylo/

07/14/2026

When it comes to an anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) diagnosis, no journey is the same. Open communication and collaboration can help individuals and their caregivers navigate decisions, while weighing factors like efficacy and side effects.

Learn about the preferences guiding these conversations: https://www.lungcancerjournal.info/article/S0169-5002(26)00510-6/fulltext

06/03/2026

Patti knows that living with polycythemia vera (PV) can come with setbacks and surprises, but difficult moments don’t define the whole journey. Patti has continued to move forward with resilience and hopes to inspire others to do the same.

Learn more: Takeda.info/UnderstandingPV

05/28/2026

Patti’s lessons for living with polycythemia vera (PV): Track symptom patterns, don’t be afraid to ask questions, and regularly follow up with a doctor. Understanding PV is key to managing it.

See Patti’s full story here: Takeda.info/UnderstandingPV

05/19/2026

At our Oncology Town Hall, Daad, living with metastatic colorectal cancer (mCRC), sat down with Michael Sapienza, CEO of the Colorectal Cancer Alliance, and Rushi Potdar, Chief Medical Officer, Global Oncology at Takeda, to discuss the growing impact of CRC on patients and families.

Their conversation highlighted the essential role of advocacy groups in helping to address the physical and emotional burdens of managing their disease, especially given that 79% of mCRC patients report feeling alone in their experience, as reported by the 2024 Harris Poll Survey. The discussion highlighted the value of engaging these groups early and keeping the patient perspective at the forefront for providers, industry, and policymakers, especially as we work to bring innovative treatments to patients more quickly.

Learn how we’re working together with our patient advocacy partners, including Colorectal Cancer Alliance, to create resources that support and empower patients: www.UnderstandingmCRC.com

05/14/2026

The impact of polycythemia vera (PV) can go beyond what others can see or understand. For Patti, the fatigue she experiences as a symptom of PV can interfere with her daily activities – even something as simple as walking up the stairs.

In this video, Patti opens up about the hidden burden of PV and shares how she plans ahead and listens to her body. Watch here: Takeda.info/UnderstandingPV

03/27/2026

This Colorectal Cancer Awareness Month, united for to support everyone affected by colorectal cancer ( ). Together with patient advocacy groups, we’re raising awareness and helping patients feel seen, supported, and never alone.

03/26/2026

Lung is not one-size-fits-all. Every diagnosis is personal, and care should be, too.

Knowing what differentiates anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) is essential for tailored care and treatment.

Check out our ALK+ NSCLC advocacy resources to learn more: https://www.takedaoncology.com/patients/lung-cancer/

03/23/2026

Jenna shares why connecting with people who truly understand living with metastatic colorectal cancer ( ) can be so powerful. She has found this connection and support through patient advocacy groups like BLKHLTH, Family Reach, Colontown - Here With You. and Colorectal Cancer Alliance.

Learn more about Jenna’s story: https://shire.co/3NBDgby

03/16/2026

This Colorectal Cancer (CRC) Awareness Month, we’re continuing to highlight the power of advocacy and community. After her first year living with metastatic colorectal cancer (mCRC), Jenna struggled with both physical and emotional challenges.

Connecting with patient advocacy groups helped instill hope, introducing her to critical resources, support and people who understood what she was going through.

Watch Jenna’s full story: https://shire.co/4sdDWmv

Address

Cambridge, MA

Telephone

+18668352233

Website

http://www.takedaoncology.com/

Alerts

Be the first to know and let us send you an email when Takeda Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Takeda Oncology:

Want your business to be the top-listed Health & Beauty Business in Cambridge?